THE SER 460 TO PRO SUBSTITUTION OF THE PROTEIN-S-ALPHA (PROS1) GENE IS A FREQUENT MUTATION ASSOCIATED WITH FREE PROTEIN-S (TYPE-IIA) DEFICIENCY
BLOOD
Authors: DUCHEMIN, J; GANDRILLE, S; BORGEL, D; FEURGARD, P; ALHENCGELAS, M; MATHERON, C; DREYFUS, M; DUPUY, E; JUHANVAGUE, I; AIACH, M
Abstract
A Ser 460 to Pro mutation of protein S (PS), involving a T to C transition in exon XIII of the protein S alpha (PROS1) gene and known as the Heerlen polymorphism, was found in 16 of 85 symptomatic patients with PS deficiency (18.8%) and only 1 of 113 healthy subjects (0.8%). Another frequent polymorphism was described in exon XV of the PROS1 gene, in the codon for Pro 626 (CCA/CCG). We found that Heerlen polymorphism was associated with allele CCA and not with allele CCG, suggesting a probable transmission by a common ancestor. Most subjects bearing the Ser 460 to Pro mutation were deficient in free PS, but had normal total PS levels. Normal levels of the C4b-binding protein (C4b-BP) isoform containing a beta chain (C4b-BP beta(+)) ruled out increased C4b-BP beta(+) as a cause of the free-PS deficiency. The binding curves of the mutated (Heerlen) PS on C4b-BP immobilized on microplates were biphasic, suggesting that one molecule of C4b-BP can bind two molecules of Heerlen PS. Because normal PS binds to C4b-BP with 1:1 stoichiometry, this may explain the free-PS deficiency observed in patients carrying the Ser 460 to Pro mutation. (C) 1995 by The American Society of Hematology.
Genotype and Laboratory and Clinical Phenotypes of Protein S Deficiency
AMERICAN JOURNAL OF CLINICAL PATHOLOGY
Authors: Duebgen, Sebastian; Kauke, Teresa; Marschall, Christoph; Giebl, Andreas; Lison, Susanne; Hart, Christina; Dick, Andrea; Spannagl, Michael
Abstract
The diagnosis of thrombophilia caused by protein S deficiency remains difficult. From 2005 to 2010, we documented 135 patients with suspected hereditary protein S deficiency for whom mutational analysis of the PROS 1 gene had been performed by direct double-stranded sequencing of the amplified 15 exons including splice sites. Multiplex ligation-dependent probe amplification was performed on 12 of 15 exons in cases with no mutation found but a large deletion in the PROS 1 gene was suspected. Mutations were identified in 49 patients, 9 by familial screening. Altogether, 17 new and 11 previously described mutations of PROS 1 were identified among the 49 patients. After the exclusion of acquired protein S deficiency due to pregnancy or hormonal contraceptives, there remained only 1 case with protein S activity levels less than 40% that could not be explained by sequence variations or deletions in the examined regions of the PROS1 gene. After the exclusion of conditions associated with acquired protein S deficiency, persistently low protein S activity levels are highly indicative of a genetic alteration in PROS1. We observed a clear correlation between the laboratory phenotype and the type of mutation.